Psychemedics Profit Margin 2010-2024 | PMD

Current and historical gross margin, operating margin and net profit margin for Psychemedics (PMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Psychemedics net profit margin as of December 31, 2024 is -9.26%.
Psychemedics Annual Profit Margins
Psychemedics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical MED-OUTP/HM CRE $0.000B $0.020B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) US $19.795B 19.51
Encompass Health (EHC) US $11.676B 24.77
DaVita (DVA) US $10.795B 14.33
Chemed (CHE) US $8.394B 26.38
Option Care Health (OPCH) US $5.268B 23.48
Elanco Animal Health (ELAN) US $4.701B 10.41
RadNet (RDNT) US $3.916B 82.87
Amedisys (AMED) US $3.124B 21.01
LifeStance Health (LFST) US $2.536B 0.00
Addus HomeCare (ADUS) US $1.912B 21.88
Astrana Health (ASTH) US $1.763B 35.33
U.S Physical Therapy (USPH) US $1.084B 27.66
Pennant (PNTG) US $0.883B 35.31
Aveanna Healthcare Holdings (AVAH) US $0.878B 0.00
Atai Life Sciences (ATAI) DE $0.294B 0.00
Daxor (DXR) US $0.038B 0.00
Ontrak (OTRK) US $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) JP $0.005B 0.00